HIV & AIDS

US approves new once-a-day pill to treat HIV (Update)

A new pill to treat HIV infection—combining two previously approved drugs plus two new ones—has been approved for adults living with the virus that causes AIDS, US regulators said Monday.

Oncology & Cancer

Killer cocktail fights brain cancer

A novel immune-boosting drug combination eradicates brain cancer in mice, according to a study in The Journal of Experimental Medicine.

Oncology & Cancer

Drug combination gets advanced liver cancer patients to surgery

A combination of the kinase-inhibitor drug cabozantinib and the immunotherapy drug nivolumab can make curative surgery possible in some liver cancer patients who would normally not be considered surgery candidates.

Medications

FDA approves first pill to treat all forms of hepatitis C

Federal health officials on Tuesday approved the first pill to treat all major forms of hepatitis C, the latest in a series of drug approvals that have reshaped treatment of the liver-destroying virus.

Neuroscience

Many epilepsy patients take drug combinations that interact

In an Epilepsia analysis of 2008-2010 Medicare claims data, one in four older Americans with new-onset epilepsy and more than one-third with prevalent epilepsy received a combination of antiepileptic drugs and non-epilepsy ...

page 12 from 33